Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma
Clinical trial NCT05625594 · RECRUITING
Trial details
- NCT number
- NCT05625594
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-29
- Primary completion
- 2028-05-22
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.